Immediate Impact
2 from Science/Nature 59 standout
Citing Papers
Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons
2025 Standout
A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus
2025 Standout
Works of Sandra Jackson being referenced
Leveraging the Global Influenza Surveillance and Response System for global respiratory syncytial virus surveillance—opportunities and challenges
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Sandra Jackson | 97 | 119 | 90 | 8 | 232 | |
| Otília Lupi | 184 | 77 | 217 | 13 | 280 | |
| Guijun Ning | 77 | 117 | 60 | 11 | 212 | |
| Ameema Asad | 130 | 61 | 41 | 11 | 274 | |
| Margaret A. Tipple | 35 | 96 | 34 | 7 | 240 | |
| Kathrin Schmolke | 88 | 122 | 106 | 8 | 296 | |
| Andrés Noé | 50 | 80 | 55 | 9 | 175 | |
| Chukwuemeka Onwuchekwa | 70 | 123 | 17 | 14 | 190 | |
| Dietlind Schleiermacher | 136 | 147 | 64 | 8 | 259 | |
| Patience Kiyuka | 97 | 116 | 48 | 11 | 220 | |
| D. Fermín Argüello | 207 | 52 | 176 | 13 | 266 |
All Works
Login with ORCID to disown or claim papers
Loading papers...